The upper Gastrointestinal Endoscope Image Auxiliary Diagnostic Software developed by Wuhan ENDOANGEL Medical Technology Co., Ltd. is used for the identification of gastric cancer in endoscopic magnification mode in definitive images to assist in the diagnosis of upper gastrointestinal gastric cancer lesions. The aim of this study is to evaluate the safety and effectiveness of the software in clinical use.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
340
Diagnosis of benign and malignant lesions with the help of ENDOANGEL
Diagnosis of benign and malignant lesions without the help of ENDOANGEL
The Second Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
RECRUITINGAFROC-AUC
AFROC-AUC at the level of identified lesions in the upper gastrointestinal cancers in the trial and control groups, using a between-group comparison.
Time frame: 3 months
Cancer identification Sensitivity
The numerator is the number of true positives and the denominator is the total number of true positives and false negatives.
Time frame: 3 months
Cancer identification specificity
The numerator is the number of true negatives and the denominator is the total number of true negatives and false positives.
Time frame: 3 months
Cancer Identification Diagnosis Compliance Rate
The numerator is the total number of true positives plus true negatives, and the denominator is the total number of true positives, false positives, true negatives, and false negatives.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.